Publications by authors named "Malan Jean-Baptiste Kouame"
Article Synopsis
- A study in West Africa from 2017-2021 observed HIV seroconversion among men who have sex with men (MSM) using either event-driven or daily pre-exposure prophylaxis (PrEP) in Burkina Faso, Côte d'Ivoire, Mali, and Togo.
- 647 high-risk HIV-seronegative MSM participated, with 72.1% opting for event-driven PrEP, which had a higher HIV incidence (2.4 per 100 person-years) compared to daily PrEP (0.6 per 100 person-years).
- The study found lower adherence rates for event-driven PrEP (44.3%) compared to daily PrEP (74.9%), indicating a critical need for
Background: Access to tailored HIV prevention services remains limited for West African MSM. We assessed adherence to quarterly HIV prevention services and its impact on HIV incidence in MSM followed up in four cities in Burkina Faso, Côte d'Ivoire, Mali, and Togo.
Methods: We performed a prospective cohort study between 2015 and 2018.
Objective: Although men who have sex with men (MSM) are at high risk of STI, their access to tailored healthcare services remains limited in West Africa. We assessed the change in STI symptoms incidence over time among MSM enrolled in a quarterly HIV prevention and care programme in four cities in Burkina Faso, Côte d'Ivoire, Mali and Togo.
Methods: We performed a prospective cohort study in MSM followed up between 2015 and 2019.
Background: Men who have sex with men (MSM) are at high risk of human papillomavirus (HPV) infection. We assessed (i) the prevalence of high-risk HPV (HR-HPV) infection and associated factors, and (ii) the prevalence of vaccine-preventable HPV infections in MSM in Burkina Faso, Côte d'Ivoire, Mali, and Togo.
Methods: A cross-sectional study was conducted in 2017-2018 among MSM ≥18 years old followed in community-based clinics.
Background: Although men who have sex with men (MSM) are at high risk of hepatitis B virus (HBV) infection, they do not have access to vaccination in West Africa, which is a highly endemic region. We investigated HBV prevalence and associated factors, as well as acceptability and difficulties of vaccination in MSM enrolled in an operational research program in Burkina Faso, Côte d'Ivoire, Mali, and Togo.
Methods: We followed up 779 MSM in 2015-2018.